Evidence map›Paper›PMID 42118696›Full record

ArticleBlood2026

MLL3 and MLL4 sustain hematopoietic stem cell multipotency by opposing a B-cell default state.

Helen C Wang, Ran Chen, Wei Yang, Rohini Muthukumar, Tingting Hu, Riddhi M Patel, Emily B Casey, Elisabeth Denby, Run Zhang, Guojia Xie and 4 more

Abstract read
In one paragraph

Article in Blood, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Helen C WangDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-8887-1799
Ran ChenDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-8415-7229
Wei YangDepartment of Genetics, Washington University School of Medicine, St. Louis, MO.
Rohini MuthukumarDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-8885-6935
Tingting HuDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Riddhi M PatelDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-0169-1224
Emily B CaseyDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Elisabeth DenbyDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
Run ZhangDepartment of Genetics, Washington University School of Medicine, St. Louis, MO.ORCID 0009-0008-5017-2317
Guojia XieNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-8250-6157
Kai GeNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.ORCID 0000-0002-7442-5138
Grant A ChallenDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-4669-8814
Jeffrey J BednarskiDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0001-6902-0876
Jeffrey A MageeDivision of Hematology and Oncology, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-0766-4200

Funding

The role of Kmt2c/MLL3 in hematopoietic stem cell self-renewal, commitment and exhaustionR01HL152180 · NHLBI · WASHINGTON UNIVERSITY · PI Jeffrey Alan Magee · 2020 to 2026
$3.0M
RAG-mediated DNA Damage Responses in Immune Development and FunctionR01AI173077 · NIAID · WASHINGTON UNIVERSITY · PI BEDNARSKI, JEFFREY J · 2022 to 2025
$2.6M
Inflammatory Stress Promotes Clonal Expansion of DNMT3A-mutant HSCsR01DK124883 · NIDDK · WASHINGTON UNIVERSITY · PI Grant Anthony Challen · 2020 to 2026
$2.5M
Cross-species development and credentialing of pediatric AML modelsR01CA285272 · NCI · WASHINGTON UNIVERSITY · PI Jeffery M Klco, Jeffrey Alan Magee · 2024 to 2026
$2.0M
NCI NIH HHS R01 CA285272NHLBI NIH HHS R01 HL152180NIAID NIH HHS R01 AI173077NIDDK NIH HHS R01 DK124883
6 · The paper itself

Abstract

abstractHematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) are sustained by networks of transcription factors and epigenetic regulators that prime lineage-specific programs yet maintain multipotency. Two epigenetic regulators, MLL3 and MLL4, play important but distinct roles in maintaining this balance. MLL3 promotes HSC differentiation, whereas MLL4 opposes differentiation. These activities are essential for both normal homeostasis and leukemia suppression, yet it is not clear how MLL3 and MLL4 regulate HSC and MPP gene expression to control HSC/MPP fate decisions. To resolve these mechanisms, we performed an extensive series of single-cell genomic studies after conditionally deleting Mll3, Mll4 or both genes together. Mll3 deletion had only limited effects on HSC/MPP enhancer networks at steady state, whereas Mll4 deletion led to precocious activation of myeloid enhancers. Surprisingly, compound Mll3/4 deletion eliminated all myeloid, erythroid, and megakaryocytic potential within the hematopoietic hierarchy and caused all progenitors to rapidly default to a B-cell-like identity. These changes were accompanied by widespread inactivation of HSC/MPP enhancers and superenhancers and ectopic activation of B-cell superenhancers. Disabling MLL3/4 histone methyltransferase activity did not recapitulate the pervasive changes in cell identity that were observed when MLL3 and MLL4 were fully inactivated, indicating that MLL3 and MLL4 activate HSC/MPP enhancers independently from their enzymatic activities. Our findings show that HSC/MPP multipotency requires sustained tension between MLL3/4-dependent enhancers that maintain myeloid, erythroid, and megakaryocyte potential and MLL3/4-independent enhancers that prime B-cell identity. MLL3 and MLL4 therefore serve as critical linchpins of multilineage hematopoiesis.

Indexed as

B-LymphocytesDNA-Binding ProteinsHematopoietic Stem CellsHistone-Lysine N-MethyltransferaseMultipotent Stem CellsAnimalsCell DifferentiationCell LineageHematopoiesisMiceNuclear ProteinsDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseMLL4 protein, mouseMllt3 protein, mouseNuclear Proteins

Identifiers

PMID42118696
PMCPMC13487477

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.